Cite
HARVARD Citation
Papadatos-Pastos, D. et al. (n.d.). 339 Clinical outcome and prognostic factors of patients (pts) with relapsed mesothelioma on phase I trials in the Drug Development Unit (DDU) of the Royal Marsden Hospital (RMH). European journal of cancer. pp. S67-. [Online].